Annexon, Inc.·4

Mar 4, 4:30 PM ET

Dananberg Jamie 4

4 · Annexon, Inc. · Filed Mar 4, 2026

Insider Transaction Report

Form 4
Period: 2026-03-02
Dananberg Jamie
CHIEF MEDICAL OFFICER
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-03-02$5.43/sh5,820$31,603123,582 total
Footnotes (2)
  • [F1]The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
  • [F2]This transaction was executed in multiple trades in prices ranging from $5.36 to $5.57, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Signature
/s/ Jennifer Lew, Attorney-in-Fact|2026-03-04

Documents

1 file
  • 4
    form4-03042026_040342.xmlPrimary